Literature DB >> 12955420

Serum alpha1-antitrypsin level and phenotype associated with familial moyamoya disease.

Toshiyuki Amano1, Satoshi Inoha, Chun-Ming Wu, Toshio Matsushima, Kiyonobu Ikezaki.   

Abstract

BACKGROUND: Obstructive vascular lesions at the terminal portion of the internal carotid arteries are thought to be the primary and essential lesions in moyamoya disease. The etiology remains unknown. To detect possible mediators of the thickened intima of moyamoya disease, we measured serum alpha-1-antitrypsin (alpha1-AT) levels and characterized the phenotype of patients with familial moyamoya disease. PATIENTS AND METHODS: Fifty-six individuals were examined, including 29 patients with moyamoya disease from 14 families. Serum alpha1-AT levels were analyzed by electroimmunoassay and genomic phenotype by isoelectric focusing.
RESULTS: All individuals had a normal alpha1-AT phenotype. The average serum alpha1-AT level in moyamoya disease patients was significantly higher than that of normal individuals, although both were within the normal range.
CONCLUSIONS: These findings suggest that serum alpha1-AT level may be a marker, rather than an etiologic factor, indicating the progression of moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955420     DOI: 10.1007/s00381-003-0799-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  33 in total

1.  Linkage analysis of moyamoya disease on chromosome 6.

Authors:  T K Inoue; K Ikezaki; T Sasazuki; T Matsushima; M Fukui
Journal:  J Child Neurol       Date:  2000-03       Impact factor: 1.987

2.  Determination of alpha1-antitrypsin phenotypes by isoelectric focusing in polyacrylamide gels.

Authors:  F Kueppers
Journal:  J Lab Clin Med       Date:  1976-07

3.  Alpha-1-antitrypsin and its relevance to human disease.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  1999-04       Impact factor: 4.599

4.  Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.

Authors:  J Duranton; C Adam; J G Bieth
Journal:  Biochemistry       Date:  1998-08-11       Impact factor: 3.162

5.  Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease.

Authors:  M Yamamoto; M Aoyagi; S Tajima; H Wachi; N Fukai; Y Matsushima; K Yamamoto
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

6.  Alpha 1-antitrypsin: a guardian of vascular tissue.

Authors:  D W Cox
Journal:  Mayo Clin Proc       Date:  1994-11       Impact factor: 7.616

Review 7.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

8.  Increase in prostaglandin E(2) production by interleukin-1beta in arterial smooth muscle cells derived from patients with moyamoya disease.

Authors:  M Yamamoto; M Aoyagi; N Fukai; Y Matsushima; K Yamamoto
Journal:  Circ Res       Date:  1999-11-12       Impact factor: 17.367

9.  Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele.

Authors:  J P Faber; W Poller; S Weidinger; M Kirchgesser; R Schwaab; F Bidlingmaier; K Olek
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

10.  Alpha 1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection.

Authors:  W I Schievink; U B Prakash; D G Piepgras; B Mokri
Journal:  Lancet       Date:  1994-02-19       Impact factor: 79.321

View more
  4 in total

1.  Familial occurrence of moyamoya disease: a clinical study.

Authors:  Ho Jun Seol; Kyu-Chang Wang; Seung-Ki Kim; Yong-Seung Hwang; Ki Joong Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

Review 2.  Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.

Authors:  Kirsten B Dorschel; John E Wanebo
Journal:  Appl Clin Genet       Date:  2021-03-18

Review 3.  Moyamoya Biomarkers.

Authors:  Edward R Smith
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

4.  Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker.

Authors:  Hye Youn Sung; Ji Yeoun Lee; Ae Kyung Park; Youn Joo Moon; Inho Jo; Eun-Mi Park; Kyu-Chang Wang; Ji Hoon Phi; Jung-Hyuck Ahn; Seung-Ki Kim
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.